iBGStar blood glucometer attachment for the iPhone, developed by AgaMatrix and commercialized by Sanofi, has received FDA approval. The iBGStar uses the iPhone as a beautiful visualization tool to keep track of glucose readings, food and insulin intake, and exercise.
The device can be used independently of the iPhone to take readings and data will be transferred to the iPhone once the two are connected again.
The device has gone on sale in some EU countries earlier this year and American launch is expected shortly.
The iBGStar™ Diabetes Manager App has a range of features that allow users multiple ways to analyze their glucose patterns over time. Patients can record and track readings, carbohydrate intake and insulin doses if taking insulin. Scorecards show individual test results and are color coded so that high and low blood glucose results can be more easily identified. The ‘Share’ function enables users to select specific data to send as an e-mail to their healthcare professional. The application can be downloaded for free from the App Store.
The iBGStar™ uses patented Dynamic Electrochemistry®1 technology that provides accurate results by helping to detect and correct for errors caused by differences in hematocrit 2 levels, manufacturing variations and certain environmental conditions
Flashback: Sanofi-aventis and AgaMatrix Unveil iBGStar Plug-In Glucose Meter for the iPhone
Press release: iBGStar™ Blood Glucose Monitoring System Receives U.S. FDA 510(k) Clearance
(hat tip: MobiHealthNews)